NDC 17856-0120

CaroSpir

Carospir

CaroSpir is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Atlantic Biologicals Corp.. The primary component is Spironolactone.

Product ID17856-0120_16683cbd-f833-40d0-ae1b-6526c06f6276
NDC17856-0120
Product TypeHuman Prescription Drug
Proprietary NameCaroSpir
Generic NameCarospir
Dosage FormSuspension
Route of AdministrationORAL
Marketing Start Date2018-08-22
Marketing CategoryNDA / NDA
Application NumberNDA209478
Labeler NameATLANTIC BIOLOGICALS CORP.
Substance NameSPIRONOLACTONE
Active Ingredient Strength25 mg/5mL
Pharm ClassesAldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 17856-0120-1

72 CUP in 1 BOX (17856-0120-1) > 2.5 mL in 1 CUP (17856-0120-2)
Marketing Start Date2020-05-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 17856-0120-1 [17856012001]

CaroSpir SUSPENSION
Marketing CategoryNDA
Application NumberNDA209478
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-05-20
Inactivation Date2020-01-31
Reactivation Date2020-05-20

Drug Details

Active Ingredients

IngredientStrength
SPIRONOLACTONE25 mg/5mL

OpenFDA Data

SPL SET ID:07504afc-f0b6-40f6-8719-cd1c3e67fc35
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 104232
  • Pharmacological Class

    • Aldosterone Antagonist [EPC]
    • Aldosterone Antagonists [MoA]

    NDC Crossover Matching brand name "CaroSpir" or generic name "Carospir"

    NDCBrand NameGeneric Name
    17856-0120CaroSpirCaroSpir
    46287-020CaroSpirCaroSpir

    Trademark Results [CaroSpir]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CAROSPIR
    CAROSPIR
    86418628 5365294 Live/Registered
    CMP Development, LLC
    2014-10-08

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.